Abstract
Pancreatic neuroendocrine neoplasms (PanNENs) are a heterogeneous group of rare tumors of the pancreas originating from totipotential stem cells or differentiated mature endocrine cells within the exocrine gland. [1] Although rare, occurring in fewer than 1 in 100,000 people per year [2, 3], the frequency of PanNENs is progressively increasing as a result of better awareness by clinicians, radiologists, and pathologists [2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kaltsas GA, Besser GM, Grossman AB (2004) The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 25:458–511
Eriksson B, Oberg K (2000) Neuroendocrine tumours of the pancreas. Br J Surg 87:129–131
Lam KY, Lo CY (1997) Pancreatic endocrine tumour: a 22-year clinicopathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 23:36–42
Hoff A, Cote G, Gagel R (2004) Management of neuroendocrine cancers of the gastrointestinal tract: islet cell carcinoma of the pancreas and other neuroendocrine carcinomas. In: Abbruzzese J, Evans D, Willett C, Fenoglio-Preiser C (eds.) Gastrointestinal oncology. Oxford University Press, New York, pp. 780–800
Solcia E, Capella C, Kloppel G (1997) Tumors of the pancreas, vol fasc 20. AFIP atlas of tumor pathology, 3rd edn. Armed Forces Institute of Pathology, Washington DC
Dixon E, Pasieka JL (2007) Funtioning and nonfuntioning neuroendocrine tumors of the pancreas. Curr Opin Oncol 19:30–35
Rockall AG, Reznek RH (2007) Imaging of neuroendocrine tumours (CT/RM/US). Best Pract Res Clin Endocrinol Metab 21:43–68
Modlin IM, Oberg K, Chung DC et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61–72
Kloppel G, Heitz PU (1988) Pancreatic endocrine tumors. Pathol Res Pract 183:155–168
Phan GQ, Yeo CJ, Hruban RH et al (1998) Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 2:472–482
Falconi M, Bonora A, Bassi C et al (2000). In: Pederzoli P, Bassi C (eds) Pancreatic tumors. Achievement and prospective. Thieme, Struttugart, pp. 368–397
Falconi M, Bettini R, Boninsegna L et al (2006) Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 7:150–156
Foti G, Boninsegna L, Falconi M, Pozzi Mucelli R (2012) Preoperative assessment of nonfunctioning pancreatic endocrine tumors: role of MDCT and MRI. Rad Med (in press)
Solcia E, Kloppel G, Sobin L et al (2000) Histological typing of endocrine tumours. World Health Organization International Histological Classification of Tumours, 2nd edn. Springer, Berlin
Fugazzola C, Procacci C, Bergamo Andreis IA et al (1990) The contribution of ultrasonography and computed tomography in the diagnosis of nonfunctioning islet cell tumors of the pancreas. Gastrointest Radiol 15:139–44
Hessel SI, Siegelman SS, McNeil BI (1982) A prospective evaluation of computed tomography and ultrasound of the pancreas. Radiology 143:129–133
D’Onofrio M, Mansueto G, Vasori S (2003) Contrast enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med 22:4413–4417
D’Onofrio M, Zamboni G, Faccioli N et al (2007) Ultrasonography of the pancreas. Contrastenhanced imaging. Abdominal Imaging 32:171–181
D’Onofrio M, Malagò R, Zamboni G et al (2005) Contrast-enhanced ultrasonography better identifies pancreatic tumor vascolarization than helical CT. Pancreatology 5:398–402
D’Onofrio M, Mansueto G, Falconi M et al (2004) Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 29:246–258
Schumacher B, Liibke HI, Frieling T (1996) Prospective study on the detection of insulinomas by endoscopic ultrasonography. Endoscopy 28:273–276
Gress FG, Barawi M, Kim D, Grendell IH (2002) Preoperative localization of a neuroendocrine tumor of the pancreas with EUS-guided line needle tattooing. Gastrointest Endosc 55:594–597
Alsohaibani F, Bigam D, Kneteman N et al (2008) The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumours. Can J Gastroenterol 22:817–820
Gunther RW, Klose KI, Ruckert K et al (1985) Localization of small islet-cell tumors. Preoperative and intraoperative ultrasound, computed tomography, arteriography digital subtraction angiography, and pan-creatic venous sampling. Gastrointest Radiol 10:145–152
Malagò R, D’Onofrio M, Zamboni GA et al (2009). Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. Am J Roentgenol 192:424–30
Hayakawa T, Iin CX, Hirooka Y (2000) Endoscopic ultrasonography of the pancreas: new advances. IOP 1:46–48
Lewis MA, Thompson GB, Young WF Jr (2012) Preoperative Assessment of the Pancreas in Multiple Endocrine Neoplasia Type 1. World J Surg [Epub ahead of print]
Procacci C, Carbognin G, Accordini S et al (2001) Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol 11:1175–1183
lglesias A, Arias M, Casal M et al (2001) Unusual presentation of a pancreatic insulinoma in helical CT and dynamic contrast-enhanced MR imaging: case report. Eur Radiol 11:926–930
Stafford Iohnson DB, Francis IR, Eckhauser FE et al (1998) Dual-phase helical CT of nonfunctioning islet cell tumors. Comput Assist Tomogr 22:59–63
Ichikawa T, Peterson MS, Federle MPet al (2000) lslet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 216:163–171
McNulty NI, Francis R, PlattIF et al (2001) Multi-detector row helical CT of is pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature and pancreatic adenocarcinoma. Radiology 220:97–102
Graziani R, Brandalise A, Bellotti M et al (2010). Imaging of neuroendocrine gastroenteropancreatic tumours. Radiol Med 115:1047–1064
Chung MI, Choi BI, Han IK et al (1997) Functioning islet cell tumor of the pancreas. Localization with dynamic spiral CT. Acta Radiol 38:135–138
Boninsegna L, Partelli S, D’Innocenzio MM et al (2010) Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior. Neuroendocrinology 92:246–251
Debray MP, Geoffroy O, Laissy IP et al (2001) Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br I Radiol 74:1065–1070
Keogan MT, McDermott VG, Paulson EK et al (1997) Pancreatic malignancy: effect of dualphase helical CT in tumor detection and vascular opacification. Radiology 205:513–518
Van Hoe L, Gryspeerdt S, Marchal G et al (1995) Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. Am J Roentgenol 165:1437–1439
Koito K, Namieno T, Nagakawa T, Morita K (1997) Delayed enhancement of islet cell carcinoma on dynamic computed tomography: a sign of its malignancy. Abdom Imaging 22:304–306
Kalra MK, Maher MM, Mueller PR et al (2003) State-of-the-art imaging of pancreatic neoplasms. Br J Radiol76:857–865
Sung ER, Seung EJ, Kang HL et al (2007) CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. European Journal of Radiology 62 371–377
Caramella C, Dromain C, De Baere T et al (2010) Endocrine pancreatic tumours: which are the most useful MRI sequences? Eur Radiol 20:2618–27
Carlson B, Iohnson CD, Stephens DH et al (1993) MRI of pancreatic islet cell carcinoma. J Comput Assist Tomogr 17:735–740
Buetow PC, Miller DL, Parrino TV, Buck IL (1997) lslet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. Radiographics 17:453–472
Owen NI, Sohaib SA, Peppercorn PD et al (2001) MRI of pancreatic neuroendocrine tumours. Br I Radiol 74:968–973
Lewis RB, Lattin GE, Paal E (2010). Pancreatic endocrine tumors: radiologicalclinicopathological correlation. Radiographics 30:1445–64
Petersein I, Spinazzi A, Giovagnoni A et al (2000) Focal liver lesions: evaluation of the efiicacy of gadobenate dimeglumine in MR imaging — a multicenter phase III clinical study. Radiology 215:727–736
Motosugi U, Ichikawa T, Morisaka H et al (2011) Detection of Pancreatic Carcinoma and Liver Metastases with Gadoxetic Acid-enhanced MR Imaging: Comparison with contrast-enhanced multi-detector row CT. Radiology 260:446–453
Doppman IL, Nieman L, Miller DL et al (1989) Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients. Radiology 172:115–124
Vinik A1, Moattari AR, Cho K, Thompson N (1990) Transhepatic portal vein catheterization for localization of sporadic and MEN gastrinomas: a ten-year experience. Surgery 107:246–255
Howard TI, Stabile BE, Zinner MI et al (1990) Anatomic distribution of pancreatic endocrine tumors. Am I Surg 159:258–264
Thoeni RF, Mueller-Lisse UG, Chan R et al (2001) Detection of small, functional islet cell tumors in the pancreas: selection of MRI Imaging sequences for optimal sensitivity. Radiology 214:483–490
Kraus BB, Ros PR (1994) Insulinoma: diagnosis with fat-suppressed MR imaging. AJR 162:69–70
Frucht H, Doppman IL, Norton IA et al (1989) Gastrinomas: comparison of MR imaging with CT, angiography, and US. Radiology 171:713–717
Pisegna IR, Doppman IL, Norton IA et al (1993) Prospective comparative study of the ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci 38:1318–1328
Bansal R, Tierney W, Carpenter S et al (1999) Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 49:19–25
Kloppel G, Heitz PU (1988) Pancreatic endocrine tumors Pathol Res Pract 183:155–168
Iaffe BM (1987) Surgery for gut hormone-producing tumors. Am I Med 82:68–76
Krejs GI (1987) V1Poma syndrome. Am I Med 82:37–48
Bloom SR, Polak IM (1987) Glucagonoma syndrome. Am J Med 82:25–36
Solivetti FM, Giunta S, Caterino M et al (2001) CT findings in a case of glucagonoma with necrolytic migrating erythema. Radiol Med (Torino) 102:410–412
Tanaka S, Yamasaki S, Matsushita H et al (2000) Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis. Pathol Int 50:146–152
Patel YC, Ganda OP, Benoit R (1983) Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma. I Clin Endocrinol Metab 57:1048–1053
Semelka RC, Custodio CM, Cem Balci N, Woosley IT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. I Magn Reson Imaging 11:141–148
Ugur O, Kothari PI, Finn RD et al (2002) Ga-66 labeled somatostatin analogue DOTADPhe1- Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. Nucl Med Biol 29:147–157
Ogawa T, Isaji S, Yabana T (2000) A case of mixed acinar endocrine carcinoma of the pancreas discovered in an asymptomatic subject. Int I Pancreatol 27:249–257
Gabata T, Terayama N, Yamashiro M et al (2005) Solid serous cystadenoma of the pancreas:MR imaging with pathologic correlation. Abdom Imaging 30:605–609
Ghavamian R, Klein KA, Stephens DH et al (2000) Renal cell carcinoma metastatic to the pancreas: clinical and radiological features. Mayo Clin Proc 75:581–585
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Mucelli, R.P., Foti, G., Romano, L. (2013). Imaging. In: Pederzoli, P., Bassi, C. (eds) Uncommon Pancreatic Neoplasms. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-2673-5_9
Download citation
DOI: https://doi.org/10.1007/978-88-470-2673-5_9
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2672-8
Online ISBN: 978-88-470-2673-5
eBook Packages: MedicineMedicine (R0)